Navigation Links
Scripps Research scientists uncover new DNA role in modifying gene function
Date:4/10/2011

JUPITER, FL, April 10, 2010 For years, scientists have thought of DNA as a passive blueprint capable only of producing specific proteins through RNA transcription. Now, research led by scientists from the Florida campus of The Scripps Research Institute has shown DNA can also act to fine-tune the activity of certain proteins known as nuclear receptors.

These new findings may make it possible to design therapies that could activate specific genes in a highly targeted manner in a number of important diseases including osteoporosis, obesity, autoimmune disease, and cancer.

The study was published April 10, 2011, in the journal Nature Structural & Molecular Biology.

"This study offers the first direct evidence of what we now recognize as critically important interactions," said team leader Patrick R. Griffin, PhD, chair of the Department of Molecular Therapeutics and director of the Translational Research Institute at Scripps Florida. "This new understanding could lead to the development of ways to promote highly targeted activity, which is exactly what you need in order to produce safe and effective therapies."

The new study focuses on the interactions between a protein complex comprising the vitamin D receptor and the retinoic X receptor and their ligands, vitamin D and 9-cis-retinoic acid (a metabolite of vitamin A), respectively, as well as DNA, and a coregulatory protein. Receptors are proteins to which one or more specific kinds of signaling molecules bind.

Scientists at Eli Lilly and Company collaborated on this study to better understand how vitamin D works at its most basic level, given that vitamin D plays a major role in bone health and is thus linked to the company's research platform in osteoporosis.

"These findings will potentially enable us to design safer medicines that work via the vitamin D pathway to help the osteoporotic patient," said Jeffrey A. Dodge, PhD, senior research fellow at Lilly. "Specifically, the technology developed at Scripps to understand these receptor ligand interactions has been critical and is a great example of industry-academia collaboration to solve important scientific questions."

Dynamic Interactions

In the new study, the scientists used a technology known as hydrogen-deuterium exchange (HDX) mass spectrometry to measure the interaction of various ligands with the vitamin D receptor complex. Ligands can be small synthetic compounds, hormones, other proteins, or DNA and they bind to large molecules such as proteins and change these molecules' behavior. In this study, the ligands were vitamin D, a metabolite of vitamin A, DNA, and a coactivator protein known as SRC1 (steroid receptor coactivator 1).

"HDX mass spectrometry is a high-precision, high-sensitivity mapping technique," Griffin explained. "With it, we can find the specific regions of the protein complex that are altered upon interaction with ligand. This information can be used to infer structural changes that are the result of a specific interaction."

In their research, the scientists found that DNA can actually alter the structure and function of the receptor complex through a wide variety of long-range structural effects. These long-range effects had been hypothesized, but this study is the first to actually detect them directly with high spatial resolution. The changes wrought by these dynamic interactions were impressive.

The study shows these binding events have substantial consequences; for example, that the DNA binding at one site alters the stability of both the ligand binding site as well as coactivator interaction surface at opposite ends of the complex and vice versa. Those alterations influence a number of key processes, from coactivator-mediated interactions with various cofactors to the modification of the DNA binding domain so that the receptor can recognize specific DNA sequences.

"There is an elaborate biochemical dialogue going on between the receptor, ligand, coregulatory proteins, and the specific DNA sequence that the nuclear receptor complex is bound to," said Griffin. "But until this study, it was not completely clear what the structural basis for this crosstalk was."


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert

Related biology news :

1. Scripps research team solves structure of beneficial virus
2. Scripps research team sheds light on immune system suppression
3. Scripps Florida scientists awarded $1.5M to fight major water and food parasites
4. Scripps research scientists identify compounds for stem-cell production from adult cells
5. Scripps research scientists identify blood component that turns bacteria virulent
6. Scripps research team defines new painkilling chemical pathway
7. Dolphin population stunted by fishing activities, Scripps/NOAA study finds
8. Scripps Research scientists shed light on how DNA is unwound so that its code can be read
9. Scripps scientists develop first examples of RNA that replicates itself indefinitely
10. Scripps scientists create first crystal structure of an intermediate particle in virus assembly
11. Historical photographs expose decline in Floridas reef fish, new Scripps study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder ... local San Diego Rotary Club. The event entitled “Stem Cells and ... had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: ...
Breaking Biology Technology: